Effect of Head-neck Rotation on I-gel™ Insertion

October 1, 2024 updated by: Karam Nam, MD, Seoul National University Hospital

Effect of Head-neck Rotation on the Success Rate At First Attempt of I-gel™ Insertion

According to previous studies, head and neck rotation reduces the tongue from being rolled back by gravity, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Study Overview

Detailed Description

I-gel™ insertion has been reported that the success rate of insertion on the first attempt is 78.5%. There may be several causes of insertion failure. Tongue folding is a major obstacle preventing appropriate i-gel™ placement. To solve this problem, the previous study has proven the efficacy of the rotational technical for I-gel™ insertion and reported a success rate of 97%.

However, the rotation of i-gel™ in the oral cavity may be limited, and it may take some learning curve to get used to it. According to previous studies, head and neck rotation increases the cross-sectional area of the upper airway, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Study Type

Interventional

Enrollment (Actual)

172

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ASA Physical Status Classification Grade 1-3
  • Patients who can provide written consent to participate in clinical trials
  • Patients requiring the I-gel™ during surgery

Exclusion Criteria:

  • Outpatient surgery
  • Patients who have the neurologic disease or cognitive impairment
  • Patients who take antipsychotic drugs
  • Body mass index > 35 kg/m2
  • Mouth opening < 2.5 cm
  • Limited neck extension or cervical mobilization (Ex: Atlanto-axial subluxation, History of cervical spine surgery or head and neck surgery)
  • Those with a recent sore throat
  • Those with weak dentation
  • Patients at risk of aspiration (Ex: Pregnancy, Gastroesophageal reflux disease or hiatus hernia)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard method
Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.
Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.
Experimental: Head-neck rotation
After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.
After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First attempt success rate
Time Frame: Induction of anesthesia during intraoperative period
After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.
Induction of anesthesia during intraoperative period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Second attempt success rate
Time Frame: Induction of anesthesia during intraoperative period
After the second attempt on insertion of i-gel™, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.
Induction of anesthesia during intraoperative period
Insertion time for successful insertion; s
Time Frame: Induction of anesthesia during intraoperative period
Time from insertion of i-gel™ into the oral cavity until appropriate placement.
Induction of anesthesia during intraoperative period
Time required for successful insertion; s
Time Frame: Induction of anesthesia during intraoperative period
Time insertion of i-gel™ into the oral cavity until After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.
Induction of anesthesia during intraoperative period
Third attempt
Time Frame: Induction of anesthesia during intraoperative period
If the attempt of assigned method fails twice, then try third attempt.
Induction of anesthesia during intraoperative period
Third attempt success rate
Time Frame: Induction of anesthesia during intraoperative period
If the attempt of assigned method fails, but the third attempt is successful with another method.
Induction of anesthesia during intraoperative period
Manipulations required rate
Time Frame: Induction of anesthesia during intraoperative period
An assistant assists when all attempt fail.
Induction of anesthesia during intraoperative period
Change to intubation
Time Frame: Induction of anesthesia during intraoperative period
Conversion rate from insertion of i-gel™ to tracheal intubation.
Induction of anesthesia during intraoperative period
Blood staining after extubation
Time Frame: Induction of anesthesia during intraoperative period
Blood stating to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Induction of anesthesia during intraoperative period
Sore throat after extubation
Time Frame: Extubation during intraoperative period
Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Extubation during intraoperative period
Hoarseness after extubation
Time Frame: Extubation during intraoperative period
Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
Extubation during intraoperative period
Sore throat at 24 hours after surgery
Time Frame: 24 hours after surgery (up to 24hours)
Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
24 hours after surgery (up to 24hours)
Hoarseness at 24 hours after surgery
Time Frame: 24 hours after surgery (up to 24hours)
Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery
24 hours after surgery (up to 24hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Karam Nam, MD, Seoul National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2022

Primary Completion (Actual)

June 2, 2023

Study Completion (Actual)

June 2, 2023

Study Registration Dates

First Submitted

December 21, 2021

First Submitted That Met QC Criteria

January 9, 2022

First Posted (Actual)

January 21, 2022

Study Record Updates

Last Update Posted (Actual)

October 3, 2024

Last Update Submitted That Met QC Criteria

October 1, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • LMA_HNRotation

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Complication of Anesthesia

Clinical Trials on Standard method

Subscribe